3533 S Alameda, Corpus Christi, TX, 78411 · (361) 739-4846
Beds
243
FY 2025
Star rating
Not rated
Overall rating
Net patient revenue
$975.3M
FY 2025
Net income
$507.7M
Patient care margin 25.8%
Discharges
3,892
Occupancy 47.8%
Clinicians
8
Medicare clinicians who work here
From the hospital's yearly cost reports (fiscal years as the hospital reports them)
Locations are shown at the center of the ZIP code.
US dollars as reported. Patient care margin = net patient revenue minus operating expenses, before other income such as grants, donations and investments.
| Fiscal year | Net patient revenue | Operating expenses | Patient care margin | Net income | Discharges | Uncompensated care | Medicare days | Medicaid days |
|---|---|---|---|---|---|---|---|---|
| 2025 | $975.3M | $723.9M | 25.8% | $507.7M | 3,892 | - | 0.1% | 7.2% |
Medicare clinicians who list this hospital, by specialty
Hospital outpatient services by payment group (APC), 2024
| Service group | Services | Patients | Medicare pays per service | All hospitals |
|---|---|---|---|---|
| APC 5183 Level 3 Vascular Procedures | - | - | - | $2,405.01 |
| APC 5072 Level 2 Excision/ Biopsy/ Incision and Drainage | - | - | - | $1,219.56 |
| APC 5073 Level 3 Excision/ Biopsy/ Incision and Drainage |
Official US government data: hospital records, ownership records, yearly cost reports and quality measures, linked by the hospital's CCN and NPI. Financials are for fiscal years as reported by the hospital.
| 2024 | $955.1M | $578.7M | 39.4% | $559.9M | 3,786 | - | 0.1% | 11.8% |
| 2023 | $694.3M | $490.1M | 29.4% | $347.4M | 3,448 | - | 0.1% | 9.6% |
| 2022 | $238.8M | $384.1M | -60.9% | -$71.4M | 3,003 | - | 0.3% | 5.8% |
| 2021 | $367.2M | $321.4M | 12.5% | $574.8M | 2,759 | - | 0.1% | 7.0% |
| 2020 | $316.6M | $284.2M | 10.2% | $241.7M | 3,056 | - | 0.3% | 9.3% |
| - |
| - |
| - |
| $2,141.49 |
| APC 5164 Level 4 ENT Procedures | - | - | - | $2,217.17 |
| APC 5165 Level 5 ENT Procedures | - | - | - | $4,436.36 |
| APC 5373 Level 3 Urology and Related Services | - | - | - | $1,516.28 |
| APC 8011 Comprehensive Observation Services | - | - | - | $2,090.36 |
Reported payments to this teaching hospital
| Company | Payments | Amount |
|---|---|---|
| Eli Lilly and Company LLY | 9 | $229K |
| Amgen Inc. AMGN | 4 | $95K |
| Pfizer Inc. PFE | 13 | $51K |
| Sanofi US Services Inc. SNY | 5 | $21K |
| Merck Sharp & Dohme LLC MRK | 3 | $10K |
| Stryker Corporation SYK | 5 | $6,964 |
| Insulet Corporation PODD | 1 | $1,500 |
| Xeris Pharmaceuticals, Inc. | 1 | $1,500 |
| Tandem Diabetes Care, Inc. TNDM | 1 | $1,500 |
| Sobi, Inc SOBI.ST | 1 | $1,000 |
Official US government data on Original Medicare hospital stays and outpatient services; groups with fewer than 11 cases are not published. Payments are those drug and device companies must report.
Driscoll Childrens Hospital is a nonprofit children's hospital in Corpus Christi, TX with 243 beds, part of Driscoll Childrens Hospital.
Driscoll Childrens Hospital in Corpus Christi, TX has 243 beds (fiscal year 2025 cost report); 189 beds are certified for Medicare. It discharged 3,892 inpatients that year, with 47.8% of its beds in use on average.
In fiscal year 2025 (ending 2025-08-31), Driscoll Childrens Hospital reported net patient revenue of $975.3M and operating expenses of $723.9M, a margin on patient care of 25.8%. After other income and expenses its net income was $507.7M (41.2% of revenue), so it made a profit that year.
Driscoll Childrens Hospital is part of Driscoll Childrens Hospital, a health system with 2 hospitals based in Corpus Christi, TX. It is a nonprofit hospital.
Driscoll Childrens Hospital has no overall star rating, usually because it reports too few quality measures (for example small, specialty or federal hospitals).
Yes, Driscoll Childrens Hospital provides emergency services.
8 Medicare clinicians list Driscoll Childrens Hospital as a hospital they work at, most often in Nephrology, Diagnostic Radiology, Cardiovascular Disease (Cardiology).
In 2025, companies reported $422K in payments to Driscoll Childrens Hospital as a teaching hospital ($15K general and $407K for research) from 14 companies.